ANDREW LINN: Open Payments
NPI 1093908832 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 15 payments from 5 companies in 2025. Trend: 2023 $398 · 2024 $290 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 8 | $187 |
| BIOTRONIK NRO, Inc. | 3 | $164 |
| Abbott Laboratories | 2 | $63 |
| ABBVIE INC. | 1 | $32 |
| Boston Scientific Corporation | 1 | $17 |
Products named: PROLATE, Prospera, PROCLAIM, QULIPTA, Clinical Trial Product, ETERNA.
Industry payments across CA — which companies pay providers there.
